SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-001352
Filing Date
2022-01-14
Accepted
2022-01-14 16:12:48
Documents
13
Period of Report
2022-01-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K isco-8k_20220113.htm   iXBRL 8-K 40984
2 EX-10.1 isco-ex101_6.htm EX-10.1 19116
  Complete submission text file 0001564590-22-001352.txt   178741

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA isco-20220113.xsd EX-101.SCH 5745
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20220113_lab.xml EX-101.LAB 16619
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20220113_pre.xml EX-101.PRE 9879
7 EXTRACTED XBRL INSTANCE DOCUMENT isco-8k_20220113_htm.xml XML 3056
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51891 | Film No.: 22532004
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences